A global MedTech ecosystem displacing expensive diagnostic imports. Built in India. Scaled for the developing world.
Request Pitch Deck & Financial ModelCervical cancer is entirely treatable if caught early, yet traditional screening fails where it is needed most.
350,000 annual deaths. 94% concentrated in developing markets. The sole cause: zero access to affordable screening.
THE LMIC CRISISExpensive, bulky imported infrastructure leaves over 98% of India's eligible population completely unscreened.
THE INDIA PROOF POINTA massive, unpenetrated global market demanding cost-effective, portable hardware paired with AI diagnostics.
SCALABLE GLOBAL TAMHigh-Barrier Hardware + High-Margin AI SaaS
We leverage proprietary hardware to anchor clinical real estate and unlock scalable SaaS revenue.
PORTABLE COLPOSCOPE
Proprietary, ultra-portable hardware engineered for low-cost, immediate deployment across hospitals, private clinics, and global NGOs.
SOFTWARE AS A MEDICAL DEVICE (SaMD)
Proprietary, real-time image analysis that empowers general clinicians to diagnose accurately, unlocking high-margin, global SaaS ARR.
EXPANDING ACCOUNT LTV
Maximizing lifetime value with active test licenses already secured for two upcoming gynecology devices, including our next-gen Hysteroscope.
BUILT-IN DISTRIBUTION
Bypassing traditional commercial entry barriers by leveraging our leadership's deep network of 15+ regional distributors and 200+ established hospital relationships.
Systematically de-risked — audited, funded, and approved by India's apex authorities.
Access our full financial models, detailed regulatory roadmap, and global market projections. Schedule a direct callback from our founding team.
Request Pitch Deck & BriefingInterested in learning more? Send us a note and we'll share our investor deck confidentially.
Navigate to our specialized sections to collaborate, review documentation, or meet the team.